Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News SQI Diagnostics Inc. V.SQD

Alternate Symbol(s):  SQIDF

SQI Diagnostics are leaders in the science of lung health. We develop and manufacture respiratory health and precision medicine tests that run on SQI's automated systems. Our tests simplify and improve COVID19 antibody monitoring, Rapid Acute Lung Injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its geographical segments are the United States, Canada and Europe. More than half of its revenues come from the United States.


Recent & Breaking News (TSXV:SQD)

SQI Diagnostics (TSXV:SQD) closes first tranche of private placement

Shoran Devi 9 hours ago

SQI Diagnostics Inc. Closes First Tranche of Private Placement with Insider Participation

Canada NewsWire 17 hours ago

SQI Diagnostics Inc. Announces Private Placement of $1.0 Million

Canada NewsWire 8 days ago

DISPOSITION OF COMMON SHARES OF SQI DIAGNOSTICS INC.

Canada NewsWire 8 days ago

SQI Diagnostics Secures Up To $2 Million in FedDev Ontario Funding

PR Newswire November 10, 2022

SQI DIAGNOSTICS EXTENDS MATURITY DATE OF PIVOT CREDIT FACILITY AND ANNOUNCES DEFERRAL OF CERTAIN INTEREST PAYMENTS

Canada NewsWire October 19, 2022

SQI Diagnostics (TSXV:SQD) receives Health Canada approval of RALI-Dx Severity Triage Test

John Ballem  October 18, 2022

SQI Diagnostics Announces Health Canada Approval of RALI-Dx Severity Triage Test

PR Newswire October 17, 2022

/C O R R E C T I O N from Source -- SQI Diagnostics Inc./

Canada NewsWire October 17, 2022

SQI Diagnostics Announces Grant of Stock Options

PR Newswire August 31, 2022

SQI Diagnostics Reports Third Quarter 2022 Results

PR Newswire August 29, 2022

SQI DIAGNOSTICS EXTENDS MATURITY DATE OF PIVOT CREDIT FACILITY

PR Newswire June 20, 2022

SQI Diagnostics Inc. Announces Closing of $4.05 Million Debt Financing

PR Newswire June 17, 2022

SQI Diagnostics Reports Second Quarter 2022 Results

PR Newswire May 26, 2022

Restrictions Easing Too Soon? Testing May Be Our Last Line of Protection

Jon Brown April 21, 2022

The Med-Tech Stock Bridging the Multibillion Dollar Transplant Gap

Stockhouse Editorial April 20, 2022

SQI DIAGNOSTICS EXTENDS MATURITY DATE OF PIVOT CREDIT FACILITY

Canada NewsWire April 13, 2022

SQI Diagnostics Inc. to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT

PR Newswire March 25, 2022

New York State Approves SQI Diagnostics' EXACT COVID-19 Antibody Assay

PR Newswire March 3, 2022

SQI Diagnostics Reports First Quarter 2022 Results

PR Newswire February 28, 2022